Eltringham Ian, Pickering Julie, Gough Helen, Preece Clair L, Perry John D
Microbiology Department, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Microbiology Department, Bedford Hospital, Bedford, United Kingdom.
J Clin Microbiol. 2016 Aug;54(8):2047-50. doi: 10.1128/JCM.00630-16. Epub 2016 May 25.
Nontuberculous mycobacteria (NTM) are an important cause of pulmonary disease in patients with cystic fibrosis (CF). A new culture medium (RGM medium) for the isolation of rapidly growing mycobacteria from the sputum of cystic fibrosis patients has recently been reported. The aim of this study was to compare culture of sputum samples on RGM medium with culture using a standard automated liquid culture method. Sputum samples were obtained from 187 distinct patients with CF attending King's College Hospital, London, United Kingdom. Each sample was decontaminated with 3% oxalic acid and inoculated into a mycobacterial growth indicator tube (MGIT) that was monitored for 42 days using the Bactec MGIT 960 instrument. Each sample was also cultured, without decontamination, onto RGM medium, which was incubated for 10 days at 30°C. Mycobacteria were isolated from 28 patients (prevalence, 15%). Mycobacteria were detected in 24 samples (86%) using the MGIT and in 23 samples (82%) using RGM medium (P = 1.00). In this setting, RGM medium showed sensitivity equivalent to that of the MGIT for isolation of NTM from the sputum of patients with CF. RGM medium offers a simple, convenient tool that can be embedded into routine culture methods, allowing the culture of all sputum samples that are submitted from patients with CF.
非结核分枝杆菌(NTM)是囊性纤维化(CF)患者肺部疾病的重要病因。最近有报道称一种用于从囊性纤维化患者痰液中分离快速生长分枝杆菌的新型培养基(RGM培养基)。本研究的目的是比较RGM培养基上痰液样本培养与使用标准自动化液体培养方法培养的效果。痰液样本取自英国伦敦国王学院医院的187例不同的CF患者。每个样本用3%草酸进行去污处理,然后接种到分枝杆菌生长指示管(MGIT)中,使用Bactec MGIT 960仪器监测42天。每个样本还在未去污的情况下接种到RGM培养基上,在30°C下孵育10天。从28例患者中分离出分枝杆菌(患病率为15%)。使用MGIT在24个样本(86%)中检测到分枝杆菌,使用RGM培养基在23个样本(82%)中检测到分枝杆菌(P = 1.00)。在这种情况下,RGM培养基在从CF患者痰液中分离NTM方面显示出与MGIT相当的敏感性。RGM培养基提供了一种简单、方便的工具,可融入常规培养方法,允许对CF患者提交的所有痰液样本进行培养。